coronavirus

The template describes the data and information that should be submitted for EUA of collection kits or tests with a home self-collection component.

The researchers also found that COVID-19 patients had a special trigger host immune response in certain pathways, such as interferon gamma signaling.

The deal will join Tangen's GeneSpark point-of-care instrument with LabWare's portable disease surveillance kit for SARS-CoV-2.

The test uses a proprietary at-home PCR nasal swab test with a turnaround time of 24 hours and is authorized for use by at-risk people.

The company is also working on a diagnostic COVID-19 test, called LamPore, that will run on its MinIon and GridIon nanopore sequencing platforms

The findings suggested recovered patients could still be viral carriers and might benefit from further monitoring after their release from the hospital.

The company said that by the end of June it would have made available more than 500,000 kits, which allow individuals to self-collect nasal samples at home.